These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30560763)

  • 1. Efficacy and safety of idalopirdine for Alzheimer's disease: a systematic review and meta-analysis.
    Matsunaga S; Fujishiro H; Takechi H
    Int Psychogeriatr; 2019 Nov; 31(11):1627-1633. PubMed ID: 30560763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease: Three Randomized Clinical Trials.
    Atri A; Frölich L; Ballard C; Tariot PN; Molinuevo JL; Boneva N; Windfeld K; Raket LL; Cummings JL
    JAMA; 2018 Jan; 319(2):130-142. PubMed ID: 29318278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of idalopirdine, a 5-HT6 receptor antagonist, in patients with moderate Alzheimer's disease (LADDER): a randomised, double-blind, placebo-controlled phase 2 trial.
    Wilkinson D; Windfeld K; Colding-Jørgensen E
    Lancet Neurol; 2014 Nov; 13(11):1092-1099. PubMed ID: 25297016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Open-Label, Multicenter, Phase III Extension Study of Idalopirdine as Adjunctive to Donepezil for the Treatment of Mild-Moderate Alzheimer's Disease.
    Frölich L; Atri A; Ballard C; Tariot PN; Molinuevo JL; Boneva N; Geist MA; Raket LL; Cummings JL
    J Alzheimers Dis; 2019; 67(1):303-313. PubMed ID: 30636738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idalopirdine as a treatment for Alzheimer's disease.
    Galimberti D; Scarpini E
    Expert Opin Investig Drugs; 2015; 24(7):981-7. PubMed ID: 26022777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into globalization: comparison of patient characteristics and disease progression among geographic regions in a multinational Alzheimer's disease clinical program.
    Cummings JL; Atri A; Ballard C; Boneva N; Frölich L; Molinuevo JL; Raket LL; Tariot PN
    Alzheimers Res Ther; 2018 Nov; 10(1):116. PubMed ID: 30474567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial.
    De Jesus Moreno Moreno M
    Clin Ther; 2003 Jan; 25(1):178-93. PubMed ID: 12637119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin E for Alzheimer's dementia and mild cognitive impairment.
    Farina N; Llewellyn D; Isaac MG; Tabet N
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002854. PubMed ID: 28128435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galantamine for Alzheimer's disease.
    Olin J; Schneider L
    Cochrane Database Syst Rev; 2002; (3):CD001747. PubMed ID: 12137632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metrifonate for Alzheimer's disease.
    López-Arrieta JM; Schneider L
    Cochrane Database Syst Rev; 2006 Apr; (2):CD003155. PubMed ID: 16625573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galantamine for Alzheimer's disease.
    Olin J; Schneider L
    Cochrane Database Syst Rev; 2001; (4):CD001747. PubMed ID: 11687119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging chemical therapies targeting 5-hydroxytryptamine in the treatment of Alzheimer's disease.
    Calhoun A; Ko J; Grossberg GT
    Expert Opin Emerg Drugs; 2017 Mar; 22(1):101-105. PubMed ID: 28253832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of a loading-dose regimen versus a no-loading-dose regimen of metrifonate in the symptomatic treatment of Alzheimer's disease: a randomized, double-masked, placebo-controlled trial. Metrifonate Study Group.
    Jann MW; Cyrus PA; Eisner LS; Margolin DI; Griffin T; Gulanski B
    Clin Ther; 1999 Jan; 21(1):88-102. PubMed ID: 10090427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galantamine provides sustained benefits in patients with 'advanced moderate' Alzheimer's disease for at least 12 months.
    Blesa R; Davidson M; Kurz A; Reichman W; van Baelen B; Schwalen S
    Dement Geriatr Cogn Disord; 2003; 15(2):79-87. PubMed ID: 12566596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detecting Treatment Group Differences in Alzheimer's Disease Clinical Trials: A Comparison of Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-Cog) and the Clinical Dementia Rating - Sum of Boxes (CDR-SB).
    Wessels AM; Dowsett SA; Sims JR
    J Prev Alzheimers Dis; 2018; 5(1):15-20. PubMed ID: 29405227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Glycogen Synthase Kinase 3 Inhibitors for Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    Matsunaga S; Fujishiro H; Takechi H
    J Alzheimers Dis; 2019; 69(4):1031-1039. PubMed ID: 31156177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 5-HT
    Amat-Foraster M; Leiser SC; Herrik KF; Richard N; Agerskov C; Bundgaard C; Bastlund JF; de Jong IEM
    Neuropharmacology; 2017 Feb; 113(Pt A):45-59. PubMed ID: 27647493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rivastigmine for Alzheimer's disease.
    Birks JS; Grimley Evans J
    Cochrane Database Syst Rev; 2015 Apr; (4):CD001191. PubMed ID: 25858345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial.
    Wilcock GK; Black SE; Hendrix SB; Zavitz KH; Swabb EA; Laughlin MA;
    Lancet Neurol; 2008 Jun; 7(6):483-93. PubMed ID: 18450517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of placebo group decline in the Alzheimer's disease Assessment Scale-cognitive subscale (ADAS-Cog) in 24 week clinical trials of Alzheimer's disease.
    Irizarry MC; Webb DJ; Bains C; Barrett SJ; Lai RY; Laroche JP; Hosford D; Maher-Edwards G; Weil JG
    J Alzheimers Dis; 2008 Jul; 14(3):301-11. PubMed ID: 18599956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.